Evonik Industries (FRA:EVK) has been given a €34.00 ($39.53) price objective by Morgan Stanley in a research report issued on Friday. The firm currently has a “buy” rating on the stock. Morgan Stanley’s price target would suggest a potential upside of 38.89% from the company’s previous close.
Several other brokerages also recently commented on EVK. JPMorgan Chase & Co. reiterated a “neutral” rating on shares of Evonik Industries in a report on Tuesday, January 22nd. Berenberg Bank set a €30.00 ($34.88) target price on shares of Evonik Industries and gave the company a “buy” rating in a report on Wednesday, December 19th. Deutsche Bank set a €40.00 ($46.51) target price on shares of Evonik Industries and gave the company a “buy” rating in a report on Monday, December 3rd. UBS Group set a €21.00 ($24.42) target price on shares of Evonik Industries and gave the company a “sell” rating in a report on Tuesday, January 22nd. Finally, Nord/LB set a €29.00 ($33.72) target price on shares of Evonik Industries and gave the company a “neutral” rating in a report on Thursday, January 24th. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating and eleven have issued a buy rating to the company’s stock. Evonik Industries has an average rating of “Hold” and a consensus price target of €31.02 ($36.07).
Shares of EVK stock traded down €0.53 ($0.62) on Friday, hitting €24.48 ($28.47). The stock had a trading volume of 276,097 shares. Evonik Industries has a 12-month low of €26.78 ($31.14) and a 12-month high of €32.97 ($38.34).
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
Read More: Inflation
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.